Resources
Search >>
Search >>
In this blog post Jeff Stassi, Eurofins Analytical Services Manager, gives three tips on how to make sure that you are partnering with a testing laboratory that you can trust, and that has the expertise required to analyze your product.
Keywords:
Blog
Supplements
Learn more about the similarities and differences between the terms: fraud, defense, authenticity, and adulteration when it comes to foods, ingredients, and supplements.
This white paper will provide a brief overview of both prevention and investigation of spoilage. By focusing on principles, it will not be able to answer every question, but rather will illustrate questions to ask during product design and failure investigations.
Both Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP) can apply to testing needed for your raw materials and products. Learn how they apply during different phases of the product development process.
What really is dietary fiber according to the most recent FDA regulations? This blog will help break down the FDA’s most recent definition of fiber as well as provide examples of ingredients used in the industry today.
Food Genomics Column: In the world of regulatory and probiotic microbiology the “name” is critical.
In this white paper, you'll learn more about the details of Section 402(a)(1) of the Food Drug and Cosmetic Act that defines adulteration. What is considered contamination? How it can happen. What levels of extraneous material are acceptable? Filth analysis should be part of any HACCP plan that requires examination of raw material.
As a food manufacturer, you have several options for adding sweetness to your product, including sugars, sugar alcohols, and artificial sweeteners. But how do they compare, and how do they impact the caloric content of your final product?
Keywords:
Blog
Nutritional
Your goal is to manufacture a safe product that meets the claims on your label.
How are you ensuring that your finished product will do this?
Proactively, or retroactively?
Putting a proactive plan in place to assess ingredient safety and quality is key to producing finished products that meet all of your quality standards. Having a partnership with an accredited, independent (third-party) laboratory just in case something goes wrong is a must.
Validation of aseptic fillers intended for the production of low-acid, shelf-stable products is a core requirement of the FDA’s low-acid canned food (LACF) regulations (21CFR113 and 108.35). Microbiological challenges of the aseptic zone and packaging material sterilization cycles are important components of the validation process. These challenges are often conducted at the production site using non-pathogenic surrogate organisms that mimic the resistance of the pertinent target pathogen. This presentation will provide a brief history of the use of such surrogates for the validation of low-acid aseptic fillers along with the approach we have used to qualify the surrogates as adequate for the intended technology.”